A multidisciplinary team of researchers at KU Leuven (University of Leuven, Belgium) has developed a dental implant that gradually releases drugs from a built-in reservoir. This helps prevent and fight infections.
Our mouth contains many micro-organisms, including bacterial and fungal pathogens. On traditional dental implants, these pathogens can quickly form a so-called biofilm, which is resistant to antimicrobial drugs like antibiotics. As a result, these implants come with a significant risk of infections that may be difficult to treat.
Implant integrated into the jawbone and with a crown on the tooth.
Credit: © KU Leuven - Kaat De Cremer
Conceptual design of the dental implant. Through a cover screw underneath the crown of the tooth, the implant can easily be filled with antimicrobial drugs, anti-inflammatory agents, or substances that stimulate integration into the jawbone.
Credit: © KU Leuven - Annabel Braem
KU Leuven researchers have now developed a new dental implant that reduces the risk of infections. "Our implant has a built-in reservoir underneath the crown of the tooth," explains lead author Kaat De Cremer. "A cover screw makes it easy to fill this reservoir with antimicrobial drugs.
The implant is made of a porous composite material, so that the drugs gradually diffuse from the reservoir to the outside of the implant, which is in direct contact with the bone cells. As a result, the bacteria can no longer form a biofilm."
In the lab, the implant was subjected to various tests for use with chlorhexidine, a universal mouthwash with a powerful antimicrobial effect.
The study shows that the Streptococcus mutans, a type of mouth bacteria that affect the teeth, can no longer form biofilms on the outside of the implant when the reservoir is filled with the mouthwash.
Biofilms that were grown beforehand on the implant could be eliminated in the same way. This means that the implant is effective in terms of both preventing and curing infections.
This study was led by Dr Karin Thevissen, Dr Kaat De Cremer, and Dr Annabel Braem. It is a collaboration between the KU Leuven Centre for Microbial and Plant Genetics, the KU Leuven Department of Materials Engineering, the KU Leuven Biomaterials Research Unit, and the KU Leuven Centre for Surface Chemistry and Catalysis. The study was funded by the KU Leuven Industrial Research Fund.
Karin Thevissen | EurekAlert!
Magnetic nanopropellers deliver genetic material to cells
08.05.2020 | Max-Planck-Institut für Intelligente Systeme
Development of new system for combatting COVID-19 that can be used for other viruses
08.04.2020 | University of Texas Medical Branch at Galveston
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Life Sciences
29.05.2020 | Physics and Astronomy
29.05.2020 | Life Sciences